TrialThe Lancet. Oncology2020

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.

Michael R Migden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.